Low Heart Rate and Blood Pressure Health and Research – Other Low Heart Rate and Blood Pressure Blood pressure and heart rates/pulses that are on the lower end of normal or even…Rigsby RigsbyMarch 9, 2022
How is Alzheimer’s disease diagnosed in a person with Down syndrome? Health and Research – Alzheimer's/Dementia How is Alzheimer’s disease diagnosed in a person with Down syndrome? Alzheimer’s disease is a progressive neurological condition. It is a type of dementia. Alzheimer’s disease…Rigsby RigsbyMarch 8, 2022
8 Tips to Promote Healthy Sleep Habits for People with Down Syndrome Healthy Living 8 Tips to Promote Healthy Sleep Habits for People with Down Syndrome Sleep disorders frequently affect individuals with Down syndrome. Growing evidence suggests that sleep disruption may…Rigsby RigsbyFebruary 8, 2022
The State of Alzheimer’s Research, with Dr Marcia Ratner & Dr James Hendrix Health and Research – Alzheimer's/Dementia The State of Alzheimer’s Research, with Dr Marcia Ratner & Dr James Hendrix Dr. Marcia Ratner & Dr. James Hendrix discuss recent developments in Alzheimer’s research.Source: Dr. Marcia…Rigsby RigsbyDecember 3, 2021
Why Patient Voices Are So Critical to the Development and Initial Approval of New Drugs Health and Research – Alzheimer's/Dementia Why Patient Voices Are So Critical to the Development and Initial Approval of New Drugs This blogpost from a former FDA insider on the power of the patient helps us…Rigsby RigsbyOctober 27, 2021
Biogen Announces New Hope for Alzheimer’s Drug Candidate Aducanumab Health and Research – Alzheimer's/Dementia Biogen Announces New Hope for Alzheimer’s Drug Candidate Aducanumab On October 22, 2019, the biopharmaceutical company, Biogen, announced that they will be going to…Rigsby RigsbyOctober 27, 2021
LuMind IDSC signs on to NTG statement re: Aduhelm Health and Research – Alzheimer's/Dementia LuMind IDSC signs on to NTG statement re: Aduhelm “It is unknown to what degree aducanumab (Aduhelm) may help people with Down syndrome, as…Rigsby RigsbyOctober 27, 2021
LuMind IDSC and Other National Groups Urge CMS to Include DS Community in Alzheimer’s Drugs Coverage Health and Research – Alzheimer's/Dementia LuMind IDSC and Other National Groups Urge CMS to Include DS Community in Alzheimer’s Drugs Coverage LuMind IDSC has joined the National Down Syndrome Society (NDSS) and The National Task Group…Rigsby RigsbyOctober 27, 2021
FDA Approves Biogen’s Aduhelm, the First New Drug for Alzheimer’s Disease Since 2003 Health and Research – Alzheimer's/Dementia FDA Approves Biogen’s Aduhelm, the First New Drug for Alzheimer’s Disease Since 2003 Today marks an important milestone in Alzheimer’s disease research with the approval by the FDA…Rigsby RigsbyOctober 27, 2021
Biomarkers and Therapeutics for People with Down Syndrome and Alzheimer’s Disease Health and Research – Alzheimer's/Dementia Biomarkers and Therapeutics for People with Down Syndrome and Alzheimer’s Disease The NTG brought together a national panel of expert researchers and practitioners in the field…Rigsby RigsbyOctober 20, 2021